prednisone has been researched along with Cardiac Toxicity in 14 studies
Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone (RCHOP) chemotherapy in non-Hodgkin's lymphoma (NHL) has risk of cardiotoxicity." | 8.31 | Myocardial work-A new tool for early detection of rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone chemotherapy induced-cardiotoxicity in hematological patients. ( Balinisteanu, A; Memis, H; Mihaila, S; Mihalcea, D; Vinereanu, D; Vladareanu, AM, 2023) |
| "While abiraterone acetate (AA) has demonstrated survival benefit in advanced prostate cancer (APC), meaningful cardiotoxicity is observed." | 5.41 | Association between RCT methodology and disease indication with mineralocorticoid-related toxicity for patients receiving abiraterone acetate for advanced prostate cancer: A meta-analysis of RCTs. ( Hall, ME; Klaassen, Z; Laviana, AA; Luckenbaugh, AN; Magee, DE; Padgett, WJ; Satkunasivam, R; Schaffer, K; Wallis, CJD, 2023) |
| "Rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone (RCHOP) chemotherapy in non-Hodgkin's lymphoma (NHL) has risk of cardiotoxicity." | 4.31 | Myocardial work-A new tool for early detection of rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone chemotherapy induced-cardiotoxicity in hematological patients. ( Balinisteanu, A; Memis, H; Mihaila, S; Mihalcea, D; Vinereanu, D; Vladareanu, AM, 2023) |
| "CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone) represents standard chemotherapy in non-Hodgkin's lymphoma (NHL) with risk of cardiotoxicity." | 3.96 | 3D echocardiography, arterial stiffness, and biomarkers in early diagnosis and prediction of CHOP-induced cardiotoxicity in non-Hodgkin's lymphoma. ( Bruja, R; Florescu, M; Mihalcea, D; Patrascu, N; Vinereanu, D; Vladareanu, AM, 2020) |
| "We describe a case of cardiac tamponade in a patient with stage IV lung adenocarcinoma, with almost 100% expression of PDL-1, treated with pembrolizumab." | 1.51 | Cardiac tamponade in a patient with stage IV lung adenocarcinoma treated with pembrolizumab. ( Khan, AM; Mehdi, S; Munir, A; Munshi, MK; Thalody, V, 2019) |
| "Cardiotoxicity is a known risk of anthracycline treatment." | 1.48 | Cumulative anthracycline exposure and risk of cardiotoxicity; a Danish nationwide cohort study of 2440 lymphoma patients treated with or without anthracyclines. ( Baech, J; Brown, PN; El-Galaly, TC; Haaber, J; Hansen, SM; Josefsson, P; Juul, MB; Jørgensen, J; Lund, PE; Poulsen, CB; Soegaard, P; Starklint, J; Torp-Pedersen, C, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 8 (57.14) | 24.3611 |
| 2020's | 6 (42.86) | 2.80 |
| Authors | Studies |
|---|---|
| Zhou, X | 1 |
| Wang, Y | 1 |
| Li, X | 1 |
| Mihalcea, D | 2 |
| Memis, H | 1 |
| Balinisteanu, A | 1 |
| Vladareanu, AM | 2 |
| Mihaila, S | 1 |
| Vinereanu, D | 2 |
| Hall, ME | 1 |
| Padgett, WJ | 1 |
| Klaassen, Z | 1 |
| Magee, DE | 1 |
| Luckenbaugh, AN | 1 |
| Laviana, AA | 1 |
| Satkunasivam, R | 1 |
| Schaffer, K | 1 |
| Wallis, CJD | 1 |
| Khan, AM | 1 |
| Munir, A | 1 |
| Thalody, V | 1 |
| Munshi, MK | 1 |
| Mehdi, S | 1 |
| Serrano, OK | 1 |
| Kutzler, HL | 1 |
| Rochon, C | 1 |
| Radojevic, JA | 1 |
| Lawlor, MT | 1 |
| Hammond, JA | 1 |
| Gluck, J | 1 |
| Feingold, AD | 1 |
| Jaiswal, A | 1 |
| Farina, K | 1 |
| Kalac, M | 1 |
| Kim, S | 1 |
| Florescu, M | 1 |
| Bruja, R | 1 |
| Patrascu, N | 1 |
| Minotti, G | 1 |
| Menna, P | 1 |
| Salvatorelli, E | 1 |
| Baech, J | 1 |
| Hansen, SM | 1 |
| Lund, PE | 1 |
| Soegaard, P | 1 |
| Brown, PN | 1 |
| Haaber, J | 1 |
| Jørgensen, J | 1 |
| Starklint, J | 1 |
| Josefsson, P | 1 |
| Poulsen, CB | 1 |
| Juul, MB | 1 |
| Torp-Pedersen, C | 1 |
| El-Galaly, TC | 1 |
| Gurdogan, M | 1 |
| Ozkan, U | 1 |
| Lunning, MA | 1 |
| Kutty, S | 1 |
| Rome, ET | 1 |
| Li, L | 1 |
| Padiyath, A | 1 |
| Loberiza, F | 1 |
| Bociek, RG | 1 |
| Bierman, PJ | 1 |
| Vose, JM | 1 |
| Armitage, JO | 1 |
| Porter, TR | 1 |
| Reichwagen, A | 1 |
| Ziepert, M | 1 |
| Kreuz, M | 1 |
| Gödtel-Armbrust, U | 1 |
| Rixecker, T | 1 |
| Poeschel, V | 1 |
| Reza Toliat, M | 1 |
| Nürnberg, P | 1 |
| Tzvetkov, M | 1 |
| Deng, S | 1 |
| Trümper, L | 1 |
| Hasenfuss, G | 1 |
| Pfreundschuh, M | 1 |
| Wojnowski, L | 1 |
| Cairoli, E | 1 |
| Danese, N | 1 |
| Teliz, M | 1 |
| Bruzzone, MJ | 1 |
| Ferreira, J | 1 |
| Rebella, M | 1 |
| Cayota, A | 1 |
| Dorokhina, EI | 1 |
| Magomedova, AU | 1 |
| Shevelev, AA | 1 |
| Kulikov, SM | 1 |
| Gitis, MK | 1 |
| Vedernikov, AV | 1 |
| Vorobyev, AI | 1 |
| Kravchenko, SK | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Early Detection of Cardiac Toxicity in Childhood Cancer Survivors[NCT03038997] | 42 participants (Actual) | Observational | 2014-11-30 | Terminated (stopped due to IRB approval expired) | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for prednisone and Cardiac Toxicity
| Article | Year |
|---|---|
Association between RCT methodology and disease indication with mineralocorticoid-related toxicity for patients receiving abiraterone acetate for advanced prostate cancer: A meta-analysis of RCTs.
Topics: Abiraterone Acetate; Antineoplastic Combined Chemotherapy Protocols; Cardiotoxicity; Humans; Hyperte | 2023 |
1 trial available for prednisone and Cardiac Toxicity
| Article | Year |
|---|---|
[Late cardiotoxicity of high-dose chemotherapy according to the modified NHL-BFM-90 program in adult patients with diffuse large B-cell lymphoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cardiotoxicity; Daunorubi | 2015 |
12 other studies available for prednisone and Cardiac Toxicity
| Article | Year |
|---|---|
Analysis of the effect of R-CHOP regimen of pegylated liposomal doxorubicin on elderly patients with stage Ⅲ-Ⅳ diffuse large B-cell lymphoma.
Topics: Age Factors; Aged; Aged, 80 and over; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Card | 2021 |
Myocardial work-A new tool for early detection of rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone chemotherapy induced-cardiotoxicity in hematological patients.
Topics: Antineoplastic Agents; Cardiotoxicity; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Non- | 2023 |
Cardiac tamponade in a patient with stage IV lung adenocarcinoma treated with pembrolizumab.
Topics: Adenocarcinoma of Lung; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Antineoplastic | 2019 |
Incidental COVID-19 in a heart-kidney transplant recipient with malnutrition and recurrent infections: Implications for the SARS-CoV-2 immune response.
Topics: Antibiotics, Antineoplastic; Bacteremia; BK Virus; Cardiomyopathy, Dilated; Cardiotoxicity; COVID-19 | 2020 |
Acute cardiomyopathy following a single dose of doxorubicin in a patient with adult T-Cell leukemia/lymphoma.
Topics: Acute Disease; Adult; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; C | 2021 |
3D echocardiography, arterial stiffness, and biomarkers in early diagnosis and prediction of CHOP-induced cardiotoxicity in non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cardiotoxicity; Cycl | 2020 |
Do You Know Pixantrone?
Topics: Antineoplastic Combined Chemotherapy Protocols; Cardiotoxicity; Clinical Trials as Topic; Cyclophosp | 2017 |
Cumulative anthracycline exposure and risk of cardiotoxicity; a Danish nationwide cohort study of 2440 lymphoma patients treated with or without anthracyclines.
Topics: Adolescent; Adult; Aged; Anthracyclines; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Comb | 2018 |
A Novel Predictor of Chemotherapeutic Cardiotoxicity in Patients with Non-Hodgkin Lymphoma.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cardiotoxicity; Cyclophosph | 2019 |
Cardiac magnetic resonance imaging for the assessment of the myocardium after doxorubicin-based chemotherapy.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Com | 2015 |
Association of NADPH oxidase polymorphisms with anthracycline-induced cardiotoxicity in the RICOVER-60 trial of patients with aggressive CD20(+) B-cell lymphoma.
Topics: Aged; Aged, 80 and over; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Cardiotoxic | 2015 |
Cumulative dose of hydroxychloroquine is associated with a decrease of resting heart rate in patients with systemic lupus erythematosus: a pilot study.
Topics: Adult; Anti-Inflammatory Agents; Antirheumatic Agents; Cardiotoxicity; Dose-Response Relationship, D | 2015 |